Prokidney (PROK) Profit After Tax (2021 - 2026)
Prokidney (PROK) reported Profit After Tax of -$42.6 million for Q1 2026, down 12.3% year-over-year from -$48.6 million in Q1 2025, and down 4.33% quarter-over-quarter from -$40.9 million in Q4 2025.
Prokidney (PROK) Profit After Tax (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Profit After Tax data on file, last reported at -$42.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$42.6 million, down 12.3% year-over-year; the trailing twelve-month figure through Mar 2026 was -$156.3 million (up 5.83% YoY), and the FY2025 annual result was -$151.6 million, up 7.18% from the prior year.
- Profit After Tax fell to -$42.6 million in Q1 2026 per PROK's latest filing, from -$40.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $78.3 million in Q4 2023 and troughed at -$67.5 million in Q1 2022.
- A 5-year average of -$33.6 million and a median of -$38.0 million in 2025 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax tumbled 15476123.78% in 2022, then surged 243.58% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$54.5 million in 2022, then surged by 243.58% to $78.3 million in 2023, then slumped by 161.96% to -$48.5 million in 2024, then rose by 15.74% to -$40.9 million in 2025, then declined by 4.33% to -$42.6 million in 2026.
- Business Quant data shows PROK's Profit After Tax at -$42.6 million in Q1 2026, -$40.9 million in Q4 2025, and -$35.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -42.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.62 Mn |
| Dec 31, 2025 | -40.85 Mn |
| Sep 30, 2025 | -35.84 Mn |
| Jun 30, 2025 | -36.97 Mn |
| Mar 31, 2025 | -37.95 Mn |
| Dec 31, 2024 | -48.48 Mn |
| Sep 30, 2024 | -41.05 Mn |
| Jun 30, 2024 | -38.47 Mn |
| Mar 31, 2024 | -35.33 Mn |
| Dec 31, 2023 | 78.26 Mn |
| Sep 30, 2023 | -41.99 Mn |
| Jun 30, 2023 | -34.82 Mn |
| Mar 31, 2023 | -36.91 Mn |
| Dec 31, 2022 | -54.50 Mn |
| Sep 30, 2022 | -33.95 Mn |
| Jun 30, 2022 | -22.13 Mn |
| Mar 31, 2022 | -67.49 Mn |
| Dec 31, 2021 | -2.32 Mn |
| Sep 30, 2021 | -17.14 Mn |
| Jun 30, 2021 | -143.00 |